CoChat

Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Objectives: To determine the prevalence of Melanocortin-4 Receptor (MC4R) mutations in a cohort of children and adolescents with overweight or obesity and to determine whether treatment responses differed between carriers and noncarriers. Methods: Using target region capture sequencing, an MC4R mutation screen was performed in 1261 Danish children and adolescents enrolled at a tertiary multidisciplinary childhood obesity treatment center. Measurements of anthropometrics, blood pressure, fasting blood biochemistry including lipid and hormone levels, and dual-energy X-ray absorptiometry were performed at baseline and throughout treatment. Results: Of 1209 children and adolescents that met all criteria to be included in the described analyses, 30 (2.5%) carried damaging or unresolved MC4R mutations. At baseline, mutation carriers exhibited higher concentrations of plasma thyroid-stimulating hormone (p = 0.003), and lower concentrations of plasma thyroxine (p = 0.010) compared to noncarriers. After a median of 1 year of treatment (range 0.5–4.0 years), body mass index (BMI) standard deviation score (SDS) was reduced in noncarriers but not in carriers, and this difference in treatment response was statistically significant (p = 0.005). Furthermore, HDL cholesterol was reduced in carriers, a response significantly different from that of noncarriers (p = 0.017). Conclusion: Among Danish children and adolescents with overweight or obesity entering a tertiary lifestyle intervention, 2.5% carried damaging or unresolved MC4R mutations. In contrast to noncarriers, carriers of damaging or unresolved MC4R mutations failed to reduce their BMI SDS during obesity treatment, indicating a need for personalized treatment based on the MC4R genotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41366-020-00673-6

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 40

Metadata

Authors
Trier, C., Hollensted, M., Schnurr, T. M., Lund, M. A. V., Nielsen, T. R. H., Rui, G., Andersson, E. A., Svendstrup, M., Bille, D. S., Gjesing, A. P., Fonvig, C. E., Frithioff-Bøjsøe, C., Balslev-Harder, M., Quan, S., Gamborg, M., Pedersen, O., Ängquist, L., Holm, J.-C., & Hansen, T.
Affiliations
  • University of Copenhagen (DK)
  • Copenhagen University Hospital (DK)
  • BGI Group (China) (CN)
  • Ferring Pharmaceuticals (Denmark) (DK)
Corresponding author
Hansen, Torben
Venue
International Journal of Obesity
Published
2020-09-13
Volume
45
Issue
1
Pages
66-76
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
OpenAlex
W3085614950
Cited by
38
References
60
Citations by year
2026: 6 · 2025: 8 · 2024: 13 · 2023: 4 · 2022: 4 · 2021: 3
FWCI
1.41
Type
journal article
Language
en
Open access
Licence
Locations
  • International Journal of Obesity (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by)
Funders
  • Innovationsfonden (0603‐00484B, 0603-00484B and 0603-00457B, 0603-00457B)
  • Danish Diabetes Academy
  • Novo Nordisk
  • Copenhagen Graduate School for Nanoscience and Nanotechnology
  • Region Sjælland (0603-00457B, 0603-00484B)
  • Novo Nordisk Fonden (NNF18SA0034956)
  • Novo Nordisk Foundation Center for Basic Metabolic Research
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
melanocortin-4 receptor, MC4R mutations, childhood obesity, adolescent obesity, overweight, lifestyle intervention, personalized treatment, thyroid-stimulating hormone, thyroxine, HDL cholesterol, body mass index, mutation prevalence
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Cross-Sectional Studies, Denmark, Humans, Life Style, Mutation, Thyrotropin, Thyroxine, Receptor, Melanocortin, Type 4, Young Adult, Pediatric Obesity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations. https://app.cochat.ai/papers/10.1038/s41366-020-00673-6
The paper
Trier, C., Hollensted, M., Schnurr, T. M., Lund, M. A. V., Nielsen, T. R. H., Rui, G., Andersson, E. A., Svendstrup, M., Bille, D. S., Gjesing, A. P., Fonvig, C. E., Frithioff-Bøjsøe, C., Balslev-Harder, M., Quan, S., Gamborg, M., Pedersen, O., Ängquist, L., Holm, J.-C., & Hansen, T. (2021). Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations. International Journal of Obesity. https://doi.org/10.1038/s41366-020-00673-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.